"Rexomun"@en . . . . . "509077-99-0" . "Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. It is a trifunctional antibody which works by linking T-lymphocytes and macrophages to the cancer cells. Phase II clinical trial evaluating the treatment of breast cancer was terminated due to change in Fresenius' development plans. (So they could concentrate on their other product catumaxomab (trade name Removab).)"@en . . "509077"^^ . "mab"@en . . . "changed"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "457120720"^^ . . . . . "Ertumaxomab"@en . . . "Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. It is a trifunctional antibody which works by linking T-lymphocytes and macrophages to the cancer cells. Phase II clinical trial evaluating the treatment of breast cancer was terminated due to change in Fresenius' development plans. (So they could concentrate on their other product catumaxomab (trade name Removab).)"@en . "none"@en . . "none"@en . "Ertumaxomab"@it . . . "9042799"^^ . "L'ertumaxomab nome commerciale Rexomun, \u00E8 un anticorpo monoclonale ibrido Topo/ratto, valutato in studi di fase II per il trattamento del tumore della mammella.Viene anche chiamato anticorpo tri-funzionale perch\u00E9 agisce collegando le cellule T, i macrofagi e le cellule cancerose insieme. Il target molecolare del farmaco \u00E8 l'antigene HER2/neu e CD3"@it . "L'ertumaxomab nome commerciale Rexomun, \u00E8 un anticorpo monoclonale ibrido Topo/ratto, valutato in studi di fase II per il trattamento del tumore della mammella.Viene anche chiamato anticorpo tri-funzionale perch\u00E9 agisce collegando le cellule T, i macrofagi e le cellule cancerose insieme. Il target molecolare del farmaco \u00E8 l'antigene HER2/neu e CD3"@it . "949616828"^^ . . . . . . . . "L5L45YGP1O"@en . . . . . . . . . . "\u0625\u0631\u062A\u0648\u0645\u0627\u0643\u0633\u0648\u0645\u0627\u0628 \u0647\u0648 \u062C\u0633\u0645 \u0645\u0636\u0627\u062F \u0648\u062D\u064A\u062F \u0627\u0644\u0646\u0633\u064A\u0644\u0629 \u0645\u062C\u0627\u0646\u0633 (\u062C\u0631\u0630\u064A-\u0641\u0623\u0631\u064A) \u0637\u0648\u0651\u0631 \u0644\u0639\u0644\u0627\u062C \u0628\u0639\u0636 \u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0623\u0648\u0631\u0627\u0645. \u0623\u0648\u0642\u0641\u062A \u0627\u0644\u062A\u062C\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064A\u0631\u064A\u0629 \u0639\u0644\u064A\u0647 \u0641\u064A \u0645\u0631\u062D\u0644\u062A\u0647\u0627 \u0627\u0644\u062B\u0627\u0646\u064A\u0629 \u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0641\u064A \u0639\u0644\u0627\u062C \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062B\u062F\u064A \u0628\u0639\u062F \u0627\u0644\u0646\u062A\u0627\u0626\u062C \u0627\u0644\u062A\u064A \u062A\u062D\u0642\u0642\u062A \u0641\u064A \u062A\u0631\u0627\u0632\u062A\u0648\u0632\u0648\u0645\u0627\u0628."@ar . . . . . . . . . . . . . . . . . . "\u0625\u0631\u062A\u0648\u0645\u0627\u0643\u0633\u0648\u0645\u0627\u0628"@ar . . "\u0625\u0631\u062A\u0648\u0645\u0627\u0643\u0633\u0648\u0645\u0627\u0628 \u0647\u0648 \u062C\u0633\u0645 \u0645\u0636\u0627\u062F \u0648\u062D\u064A\u062F \u0627\u0644\u0646\u0633\u064A\u0644\u0629 \u0645\u062C\u0627\u0646\u0633 (\u062C\u0631\u0630\u064A-\u0641\u0623\u0631\u064A) \u0637\u0648\u0651\u0631 \u0644\u0639\u0644\u0627\u062C \u0628\u0639\u0636 \u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0623\u0648\u0631\u0627\u0645. \u0623\u0648\u0642\u0641\u062A \u0627\u0644\u062A\u062C\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064A\u0631\u064A\u0629 \u0639\u0644\u064A\u0647 \u0641\u064A \u0645\u0631\u062D\u0644\u062A\u0647\u0627 \u0627\u0644\u062B\u0627\u0646\u064A\u0629 \u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0641\u064A \u0639\u0644\u0627\u062C \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062B\u062F\u064A \u0628\u0639\u062F \u0627\u0644\u0646\u062A\u0627\u0626\u062C \u0627\u0644\u062A\u064A \u062A\u062D\u0642\u0642\u062A \u0641\u064A \u062A\u0631\u0627\u0632\u062A\u0648\u0632\u0648\u0645\u0627\u0628."@ar . . . . . . . "2239"^^ . "3"^^ . . . "Rexomun"@en . . "axo"@en . "L5L45YGP1O" .